Overview


Aneurysm Treatment Market Introduction
Aneurysm Treatment Market foreseen to grow over a CAGR of 5% during 2020-2027.
Brain aneurysm, which is observed at the base of the brain, is a balloon-like or bulging growth. It typically appears in areas where larger arteries are branched into smaller ones. It is also known as intracranial aneurysm or cerebral aneurysm. Aneurysm results into stroke or brain damage due to the rupturing which results into bleeding in the sub-arachnoid area which may sometimes even lead to death. Until the swelling ruptures, brain aneurysm rarely shows any symptoms. However, localized headache, cranial nerve palsy and double vision of brain aneurysm that has a mass effect on the neurological structures adjacent to it. Some of the key causes of brain aneurysm are aging, heredity, brain injury and atherosclerosis.
It is generally treated with surgical clipping, flow diverters, and endovascular coiling.
An aneurysm is associated with fatality and has a high risk of potential complications. Rising prevalence of aneurysm is expected to fuel the growth of the market. According to the CDC, annually aneurysm contributes to more than 25,000 deaths in the U.S. and an estimated 40% of these cases can cause death in less than one day. As it is a fatal complication, an aneurysm requires immediate medical attention and has a huge demand in primary healthcare settings. Along with this, healthcare systems are more focused on preventive techniques to control the incidence. All these factors led to the potential growth of the market during the forecast period. Further, increasing awareness and increasing healthcare expenditure fuelled the growth of the market.
Developed economies like North America and Europe is expected to witness a high market share in the global market due to high awareness among the general population. Established healthcare systems and reimbursement policies in these regions are expected to drive the growth of the market. Asia-Pacific region is expected to witness a high market growth rate during the forecast period due to high prevalence. Asia Pacific region is dominated by local manufacturers and expected to remain the same throughout the forecast period. Latin America is the second fast-growing region in the global market due to increasing awareness. Rest of world accounts the small fraction of market share in the global market
Penumbra, Terumo Medical Incorporated, Medtronic Plc, Phenox GmbH B. Braun Melsungen AG, Stryker, and Raumedic AG, DePuy Synthes, Integra Life Sciences Corporation, Orsan Medical Technologies, Spiegelberg GmbH, MicroPort Scientific Corporation, Codman
Shurtleff, Inc.
Aneurysm Treatment Market
Aneurysm Treatment Market Segmentation
By Product Type
Surgical Clipping
Endovascular Coiling
Flow diverters
By End User
Hospitals
Neurological Centres
By Region
North America
Latin America
Europe
Asia Pacific
Rest of the World
Competitive Landscape

Tier 1 players- established companies in the market with a major market share

Tier 2 players

Emerging players which are growing rapidly

New Entrants
FutureWise Key Takeaways

Growth prospects

SWOT analysis

Key trends

Key data-points affecting market growth

To provide with an exhaustive analysis on the global Aneurysm Treatment Market by Product Type, by End User, and by Region

To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

To evaluate and forecast micro-markets and the overall market

To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East

To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Profiling of companies to evaluate their market shares, strategies, financials and core competencies.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Aneurysm Treatment Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Global Aneurysm Treatment Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Aneurysm Treatment Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Aneurysm Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Aneurysm Treatment Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Surgical Clipping
        2. Endovascular Coiling
        3. Flow diverters
  • 8.   Global Aneurysm Treatment Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Hospitals
        2. Neurological Centres
  • 9.   North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2020-2027
  • 10.   Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2020-2027
  • 11.   Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2020-2027
  • 12.   Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
  • 13.   Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2020-2027
  • 14.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. Penumbra
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Terumo Medical Incorporated
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Medtronic Plc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
         4. Phenox GmbH B. Braun Melsungen AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        14.5 . Stryker
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        14.6 . Raumedic AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. DePuy Synthes
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Integra Life Sciences Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Orsan Medical Technologies
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Spiegelberg GmbH
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. MicroPort Scientific Corporation
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Codman
  • 15.  Shurtleff, Inc.
    •    14.12.1. Company Overview
         14.12.2. Product Portfolio
         14.12.3. SWOT Analysis
         14.12.4. Financial Overview
         14.12.5. Strategic Overview
  • 16.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients